Cantel Medical (CMD) Tops Q3 EPS by 4c

Cantel Medical (NYSE: CMD) reported Q3 EPS of $0.16, $0.04 better than the analyst estimate of $0.12. Revenue for the quarter came in at $236.9 million versus the consensus estimate of $235.41 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c